Uninsured rates, negative outcomes continue to rise among people of color
The pandemic is widening the racial health divide – and that has significant implications for payers, marketers and other stakeholders.
Most recent articles by Marc Iskowitz
Behind ‘the apology’: Wayne Pines, who counseled FDA Commissioner Hahn to clarify plasma remarks, addresses the controversy
The comms veteran, who found himself at the center of a feud between the commissioner and HHS, also discusses concerns about the agency’s independence.
60% of med-ed providers expect revenue dip: survey
A recent survey provides a glimpse at the med-ed sector’s biggest challenges.
Bluebird chief on biotech’s usual excuse for being on low end of diversity: ‘I call bull—- on that.’
Nick Leschly stands out for the way he is prioritizing D&I, even if it’s not his forté.
‘Abysmal, but fixable:’ Inside biopharma’s renewed push to up racial and gender representation
Women of color are helping the industry become more intentional in its efforts to advance diversity.
Klick cements Grant’s CEO succession, unveils new practice areas and hires
The agency announced the promotion of Lori Grant to CEO and Leerom Segal to group CEO, along with several exec-level hires and new practice areas.
Is pharma too physician-centric? Why industry may want to rethink its approach to NPs and PAs
They’ve boosted access to care, and now NPs and PAs are seeing increased practice authority. The changes warrant an industry rethink, two clinician leaders argue.
Standing up to racism requires more than just words
Systemic racism is a public health crisis no less severe than Alzheimer’s disease or cancer. We all need to do our part in taking down the racial barriers that exist in this country.
Everybody loves pharma? Unexpected reputational gains since COVID-19 crisis
Pharma’s ambitious, all-hands-on-deck work on COVID vaccines, therapeutics and tests appears to have burnished its reputation far better than any corporate marketing effort.
